JessicaKnight-PerryMDMS

Pediatric Anemia and Red Blood Cell Hematology, Pediatric Hematologic Oncology, Pediatric Solid Tumor Oncology

Assistant Professor, Bone Marrow Transplant and Cellular Therapy

Dr. Knight-Perry is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2450 Riverside Ave
Minneapolis, MN 55454
Phone+1 612-365-8100

Fax+1 720-777-7346

The Norman Rogers Cancer Research Award Tulane University Health Science Center, 2006
Young Investigator Travel Award Pediatric Blood & Marrow Transplant Consortium, 2016

PubMed

79 citations
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transpla...
Mohamed A. Kharfan-Dabaja, Ambuj Kumar, Ernesto Ayala, Mahmoud Aljurf, Taiga Nishihori
Transplantation and Cellular Therapy. 2021-08-01
5 citations
Characterizing Immune-Mediated Cytopenias After Allogeneic Hematopoietic Cell Transplantation for Pediatric Nonmalignant Disorders
Robert Galvin, Qing Cao, Weston P. Miller, Jessica Knight-Perry, Angela R. Smith
Transplantation and Cellular Therapy. 2021-04-01
4 citations
Pediatric Metastatic Cardiac Angiosarcoma Successfully Treated With Multimodal Therapy: Case Report and Review of Literature.
Jane Koo, Jessica Knight-Perry, Csaba Galambos, Lorna P. Browne, Carrye R. Cost
Journal of Pediatric Hematology/oncology. 2021-03-01

Books/Book Chapters

The Harriet Lane Handbook
Chapter: Palliative Care
Knight-Perry, JEditors: Branden Engorn and Jamie Flerlage.Elsevier Saunders, Philadelphia, PAEdition 20th,2015

Abstracts/Posters

Low Incidence of Long-term, Persistent Graft versus Host Disease After Pediatric Unrelated Cord Blood Transplant with Minimal Graft versus Host Disease Sequelae
Knight-Perry J, Giller RH, Liptzin D, Kerby G, Sanghvi U, Alsultan A, Quinones RR, Keating A, Hild E, Benkhalil N, Law D, Cosgrove S, Peltz A, Nuechterlein B, Drake K ..., Pediatr Blood Cancer, 1/1/2016
Risk factor assignment concordance and clinical care guideline compliance for prevention of pediatric hospital-acquired venous thromboembolism
Fowlkes K, Smith N, Clark B, Knight-Perry J, Cho H, Reiter P, Wathen B, Hilden J, and Branchford B, J thromb Haemost, 1/1/2016
Venous Thromboembolism in Pediatric Cystic Fibrosis
Knight-Perry J, Towler E, Payan M, Branchford B, Martiniano SL, Sagel SD, Wang M, Blood, 1/1/2016
Diastolic Dysfunction is Associated with an Elevated Tricuspid Regurgitant Velocity in Older Individuals with Sickle Cell Disease
Knight-Perry JE, Waggoner AD, de las Fuentes L, Davila-Roman VG, Field JJ, Washington University School of Medicine, St. Louis, Doris Duke Clinical Research Fellowship Annual Meeting, 1/1/2009
Join now to see all

Doris Duke Clinical Research FellowshipDoris Duke Charitable Foundation2008–2009

Member, Children's Hospital of Colorado Center for Cancer and Blood Disorders Mentorship Taskforce 2016 - 2017
Member, Children's Hospital Colorado Venous Thromboembolism Prevention Taskforce 2015 - 2017
Member, University of Colorado Hematology/Oncology Fellow Selection Committee 2015 - 2017
Member, Cleveland Clinic Lerner College of Medicine Medical Student Selection Committee 2010 - 2011